Intestine-Mimicking Cell Model Accurately Predicts Drug Toxicity KRIBBs hIEC model detects gastrointestinal toxicity with 94% accuracy, offering early prediction of drug side effects ...

A protein, the farnesoid X receptor, that is a key modulator of fat, glucose and cholesterol levels in the body usually works in tandem with another protein, but new research shows it can also work ...

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...

While it should be thought of as a “short-term clinical tool”, there are occasions when a temporary low-residue diet can benefit the gut.

Live Science spoke with Dr. John Pandolfino, a researcher who designed a "digital twin" to help guide surgery.

Explore how transgenerational trauma affects descendants, highlighting the need for recognition and healing in communities.

ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional gut lymphatics and local inflammation linked to metabolic disease and ...

A protein that is a key modulator of fat, glucose and cholesterol levels in the body usually works in tandem with another ...

The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...

Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...

BARCELONA, Spain, March 8, 2026 /PRNewswire/ -- At MWC Barcelona 2026, Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC) presented its end-to-end all-optical solutions, highlighting ...